Phone: 203 287 8968
Website: http://revegencorp.com/

Contact(s)
[email protected]

General Information
Revegen pursues a new, innovative approach in drug discovery research built on a proprietary pdiCAD™ technological platform. We have developed a variety of tools and methods that accelerate discovery of small molecule drugs based on principles of molecular recognition between therapeutic agents and protein targets. Our methods improve resource efficiency of the drug discovery process and support development of targeted therapies in a broad spectrum of indications.

Research Activities
We envision discovery of new medicines as a process of structural engineering, derived from the understanding of the molecular architecture of a protein target and algorithmic prediction of the drug’s physicochemical and toxicological properties. Our proprietary probability density imaging (PDI) technology affords unparalleled accuracy and speed in the modeling of interactions between small organic molecules and proteins.

Back